Samuel Broder, M.D., (Celera, Chief Medical Officer) former director of the National Cancer Institute and whose lab made key contributions to the development of AIDS treatments such as AZT, ddl, and ddc, delivers a lecture entitled "The Development of Antiretroviral Therapy and Molecular Diagnostics and Their Impact on the Global HIV-1/AIDS Pandemic: Lessons in Treating the 'Untreatable'" at the Brown University Center for Computational Molecular Biology.